4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-26-010472
Options or other derivatives
- President and CEO acquired 550,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yao Zhengbin President and CEO | 2026-02-02 | Grant or award · Stock Option (right to buy) | +550,000 | 550,000 | D: show line 1 in the form |
Loading xslF345X05/tm265104-4_4seq1.xml…